Oncopeptides AB
STO:ONCO

Watchlist Manager
Oncopeptides AB Logo
Oncopeptides AB
STO:ONCO
Watchlist
Price: 5.42 SEK 1.69% Market Closed
Market Cap: 1.4B SEK

Wall Street
Price Targets

ONCO Price Targets Summary
Oncopeptides AB

Wall Street analysts forecast ONCO stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ONCO is 5.29 SEK with a low forecast of 5.24 SEK and a high forecast of 5.44 SEK.

Lowest
Price Target
5.24 SEK
3% Downside
Average
Price Target
5.29 SEK
2% Downside
Highest
Price Target
5.44 SEK
0% Upside
Oncopeptides AB Competitors:
Price Targets
ASND
Ascendis Pharma A/S
35% Upside
ADAG
Adagene Inc
392% Upside
RCUS
Arcus Biosciences Inc
43% Upside
SCLP
Scancell Holdings PLC
223% Upside
HRTX
Heron Therapeutics Inc
245% Upside
ABNX
Abionyx Pharma SA
183% Upside
BIIB
Biogen Inc
3% Upside

Revenue
Forecast

Revenue Estimate
Oncopeptides AB

The compound annual growth rate of Oncopeptides AB's revenue for the next 2 years is 188%.

N/A
Past Growth
188%
Estimated Growth
Estimates Accuracy
-23%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Oncopeptides AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat

Net Income
Forecast

Net Income Estimate
Oncopeptides AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-57%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ONCO's stock price target?
Price Target
5.29 SEK

According to Wall Street analysts, the average 1-year price target for ONCO is 5.29 SEK with a low forecast of 5.24 SEK and a high forecast of 5.44 SEK.

What is Oncopeptides AB's Revenue forecast?
Projected CAGR
188%

The compound annual growth rate of Oncopeptides AB's revenue for the next 2 years is 188%.

Back to Top